1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
692C5B8ABE9D770D000258B780043498A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-product-launch-in-cns-neurosciences-timelines-resources-success-factors-digital-influence?opendocument
18
19opendocument
2018.97.14.90
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Launch Optimization

Medical Affairs Product Launch in CNS / Neurosciences: Timelines, Resources, Success Factors, and Digital Influence

DB Image

Download FREE Excerpt

ID: 5819

Features:

7 Info Graphics

18 Data Graphics

360+ Metrics

Pages/Slides: 34

Published: 2024

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Medical Affairs Product Launch in CNS / Neurosciences: Timelines, Resources, Success Factors, and Digital Influence”

STUDY OVERVIEW

As the CNS / Neurosciences market undergoes rapid transformation, optimizing product launch preparedness is key for Medical Affairs to ensure successful outcomes. This requires precise management of launch timelines, strategic resource allocation, and leveraging digital technologies to enhance launch processes.

Best Practices, LLC undertook this benchmarking research to uncover how Medical Affairs can drive successful CNS / Neurosciences product launches. This study delves into effective timeline management, resource optimization, and the integration of digital tools, while also identifying critical success factors and common pitfalls encountered by Medical Affairs teams.

KEY TOPICS

  • CNS / Neurosciences Launch Timelines, Preparedness Metrics, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During CNS / Neurosciences Launches
  • Digital Influence on CNS / Neurosciences Launch Processes and Launch Tool Deployment

KEY METRICS

  • CNS / Neurosciences launch activities timeline for Medical Affairs
  • Medical Affairs launch budget and staffing per CNS / Neurosciences product
  • Launch dashboard and performance tracking for CNS / Neurosciences products
  • Medical Affairs’ pre and post launch budget allocation in CNS / Neurosciences segment
  • Medical Affairs’ pre and post launch staffing allocation in CNS / Neurosciences segment
  • Success factors for Medical Affairs in CNS / Neurosciences launches
  • Major pitfalls encountered by Medical Affairs during CNS / Neurosciences launches
  • Post-pandemic digital technology utilization in Medical Affairs during CNS / Neurosciences product launches
  • Digital launch tool deployment by Medical Affairs during the CNS / Neurosciences product launch cycle
  • Influence of digital activities and programs that Medical leads and supports in CNS / Neurosciences
  • Impactful digital tools for Medical Affairs’ CNS / Neurosciences launch activities

SAMPLE KEY FINDINGS

  • Digital Launch Tools: In the CNS / Neurosciences segment, digital tools are pivotal for Medical Affairs' launch strategies. Key tools include platforms like Veeva, Zoom, Microsoft Teams, and Smartsheet for digital communications, which facilitate stakeholder coordination. Insights collection software, such as Kernel, is used to gather and analyze data, providing crucial market insights. Social platforms like Facebook, LinkedIn, and X (formerly Twitter) are leveraged for information dissemination and engagement. Additionally, tools like 60 Seconds and Monocl enhance MSL engagement by supporting training and interactions. These tools collectively modernize operations and optimize launch strategies in the CNS / Neurosciences market.

METHODOLOGY

This benchmarking study engaged 30 Medical leaders from 25 leading life sciences organizations. The study insights are drawn primarily from Directors and upper management executives, representing nearly 80% of the benchmark class.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Diagnostic; Chemical; Health Care; Consulting; Communications; Consumer Products; Medical Device


Companies Profiled:
Adamas Pharmaceuticals; Apellis Pharmaceuticals; AstraZeneca; BELLUS Health; BIAL; bioMerieux; Boehringer Ingelheim; EMD Serono; Eurofarma; Genentech; Gedeon Richter ; GW Pharmaceuticals; Ipsen; Kyowa Kirin; Labaid Group; Lundbeck; MEDiSTRAVA; Merck KGaA; NexGen Healthcare Communications; Novartis; Pixacore; Sandoz; Sunovion; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH